Amanote Research

Amanote Research

    RegisterSign In

Endocannabinoids: A Promising Impact for Traumatic Brain Injury

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2017.00069
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

February 17, 2017

Authors
Lesley D. SchurmanAron H. Lichtman
Publisher

Frontiers Media SA


Related search

MicroRNA Let-7i Is a Promising Serum Biomarker for Blast-Induced Traumatic Brain Injury

Journal of Neurotrauma
Neurology
2012English

Traumatic Brain Injury

Philosophical Transactions of the Royal Society B: Biological Sciences
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2011English

Ultrasound Imaging for Traumatic Brain Injury

Journal of Ultrasound in Medicine
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2018English

Pediatric Traumatic Brain Injury

Pediatric Critical Care Medicine
Child HealthCritical CarePediatricsPerinatologyIntensive Care Medicine
2016English

Experimental Traumatic Brain Injury

Experimental and Translational Stroke Medicine
NeuroscienceCognitive Neuroscience
2010English

Cathepsin B Is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate

Frontiers in Neurology
Neurology
2015English

Mild Traumatic Brain Injury

Archives of Internal Medicine
1998English

Microglia Activation as a Biomarker for Traumatic Brain Injury

Frontiers in Neurology
Neurology
2013English

A Role for Nanoparticles in Treating Traumatic Brain Injury

Pharmaceutics
Pharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy